IMMUNOTOXIC EFFECTS OF IODINE
碘的免疫毒性作用
基本信息
- 批准号:2900224
- 负责人:
- 金额:$ 19.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-04-01 至 2001-03-30
- 项目状态:已结题
- 来源:
- 关键词:NOD mouse T lymphocyte autoantibody autoimmune disorder autoimmune thyroiditis cellular immunity clinical research cytokine dietary mineral disease /disorder model disease /disorder proneness /risk genetic disorder human subject immunopathology immunotoxicity iodination iodine molecular pathology nutrition related tag pathogenic diet thyroglobulin tissue /cell culture
项目摘要
DESCRIPTION: (Adapted from the investigator's Abstract) Autoimmune
thyroiditis is a multifactorial condition with several genetic and
environmental components contributing to disease. Iodine has been
implicated as one of these components. The broad long-term objectives
remain to explore the immunotoxic of iodine in autoimmune thyroiditis (AT).
Increased environmental exposure to iodine from dietary or therapeutic
sources may contribute to the increasing prevalence of AT in humans. Both
animal models of thyroiditis and clinical observations in humans relate
ingestion of excess iodine as a potent risk factor in subjects genetically
predisposed to AT. However, the pathogenic mechanism has not been
determined. The investigator's hypothesis is that excess ingested iodine
leads to highly iodinated Tg, and that the highly iodinated Tg is a more
potent auto-immunogen than poorly-iodinated Tg in subjects predisposed to
AT. As a new direction from their current research on humans, they will use
a mouse model as the primary test system to study the role of iodine in
triggering the expression of AT. The congenic mutant strain of NOD mice
(NOD.B10.A (4R)-H2-H4) do not get diabetes but do get thyroiditis that is
exacerbated by dietary iodine. The investigator will continue to study the
role of iodinated Tg in humans using in vitro cell techniques. The specific
aims for this proposal are: 1. To show that ingested iodine promotes AT in
the NOD mouse model and establish basic and immunological parameters. The
investigator will study the effect of iodine dose, timing, age, sex, on
disease induction, on phenotype of cells in the thyroid. He will determine
the frequency of these cells and then relate these findings to their
cytokine and antibody profiles. 2. To induce thyroiditis in vivo. He will
show that T cells from mice with lesions after a high iodine diet will
transfer disease into non-affect recipients, first, with spleen cells from
iodine-treated mice, then iodinated Tg to support the hypothesis.
Individual parameters of the immune system will be monitored as for
specifics aim 1. 3. To show in human studies that T cell clones
preferentially recognize highly iodinated Tg greater than poorly iodinated
Tg, to establish frequency of these cells by limiting dilution and determine
their cytokine profiles in order to relate these findings to disease. The
mouse model permits mechanistic research of dietary iodine that is closely
analogous to humans and allows experimental procedures that cannot be done
in humans. If the mechanism of disease can be clarified, then the potential
exists for developing strategies to abrogate the deleterious immune
response.
描述:(改编自研究者的摘要)自身免疫
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carol Lynne Burek其他文献
Carol Lynne Burek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carol Lynne Burek', 18)}}的其他基金
NOD-H2H4 MICE AS A SENTINEL MODEL FOR AUTOIMMUNE THYROID
NOD-H2H4 小鼠作为自身免疫性甲状腺的哨兵模型
- 批准号:
6382344 - 财政年份:1999
- 资助金额:
$ 19.88万 - 项目类别:
NOD-H2H4 MICE AS A SENTINEL MODEL FOR AUTOIMMUNE THYROID
NOD-H2H4 小鼠作为自身免疫性甲状腺的哨兵模型
- 批准号:
6178201 - 财政年份:1999
- 资助金额:
$ 19.88万 - 项目类别:
NOD H2H4 MICE AS A SENTINEL MODEL FOR AUTOIMMUNE THYROID
NOD H2H4 小鼠作为自身免疫性甲状腺的哨兵模型
- 批准号:
6078591 - 财政年份:1999
- 资助金额:
$ 19.88万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Discovery Grants Program - Individual